Multimodal Imaging in Central Serous Chorioretinopathy (IMO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02889185|
Recruitment Status : Terminated
First Posted : September 5, 2016
Last Update Posted : September 16, 2019
This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera.
This is a feasibility study with a limited number of patients.
|Condition or disease||Intervention/treatment||Phase|
|Central Serous Chorioretinopathy||Device: RTX1 IMAGIN EYE retinal camera||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||April 2016|
|Actual Primary Completion Date :||December 4, 2018|
|Actual Study Completion Date :||December 4, 2018|
|Experimental: Adaptative optics retinal camera||
Device: RTX1 IMAGIN EYE retinal camera
In addition to the routine examination including OCT, an imaging using RTX1 IMAGIN EYE retinal camera will be performed.
- Workability of images of RTX1 IMAGIN EYE retinal camera [ Time Frame: day 1 ]Two readings of the images captured with adaptative optics retinal camera and assessment of their workability in routine care.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02889185
|Besançon, France, 25000|
|Principal Investigator:||Maher Saleh, MD PhD||CHU Besançon|